Requires health insurance companies to cover lead screenings for children 16 years of age or younger.
Impact
Should S1450 be enacted, it represents a significant shift in health policy within New Jersey. The bill requires the Department of Health to establish regulations detailing specific screening requirements, intervals, and follow-up measures. Additionally, it emphasizes coordination with state Medicaid programs and federal children's health initiatives to maximize funding and resources for these screenings. This move not only aligns with updated federal guidelines from the Centers for Disease Control and Prevention but also underscores the state's proactive approach in combatting lead exposure in children.
Summary
Senate Bill S1450 aims to expand health insurance coverage for lead screenings specifically for children aged 16 years or younger. This legislation seeks to amend existing statutes dating back to 1995 that currently only necessitate insurance coverage for lead screenings in children under the age of six. By broadening the age limit for screening, the bill intends to facilitate the early detection of lead exposure, which poses serious health risks to child development and overall well-being. The bill reaffirms the state's commitment to protecting public health by providing necessary screenings to a more extensive segment of the pediatric population.
Contention
While the bill is primarily seen as a protective measure for children, there may be points of contention among stakeholders regarding the costs and implementation of expanded coverage. Opponents may argue that additional mandates on healthcare providers and insurers could lead to increased operational challenges or costs, potentially affecting insurance premiums. Advocates, however, maintain that the long-term health benefits of early lead detection will offset these initial challenges, ultimately contributing to healthier childhood development outcomes.
Summary_statement
In summary, S1450 addresses a critical public health issue by ensuring that health insurance plans in New Jersey cover lead screenings for a broader age range of children. By incorporating more comprehensive lead screening requirements and aligning state regulations with federal guidelines, New Jersey seeks to reduce the risk of lead poisoning and enhance the health of its youth.
Requires health insurers to cover colorectal cancer screenings for covered persons aged 33 or over and covered persons under the age of 33 if deemed medically necessary.
A bill for an act relating to testimony at involuntary commitment hearings by physician assistants and advanced registered nurse practitioners.(See HF 313.)
A bill for an act relating to testimony at involuntary commitment hearings by physician assistants and advanced registered nurse practitioners.(Formerly HSB 85.)